{"data":[{"accessionNo":"0001193805-26-001408","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":"28658R106","securityClass":"Common Stock","eventDate":"2026-10-27","reportingPerson":"James E. Flynn","reportingCik":null,"personType":"IN","sharesOwned":3070000,"percentOfClass":5.25,"filedAt":"2026-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001193805-26-001408","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":"28658R106","securityClass":"Common Stock","eventDate":"2026-10-27","reportingPerson":"Deerfield Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":3070000,"percentOfClass":5.25,"filedAt":"2026-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001193805-26-001408","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":"28658R106","securityClass":"Common Stock","eventDate":"2026-10-27","reportingPerson":"Deerfield Management Company, L.P.","reportingCik":null,"personType":"PN","sharesOwned":3070000,"percentOfClass":5.25,"filedAt":"2026-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001193805-26-001408","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":"28658R106","securityClass":"Common Stock","eventDate":"2026-10-27","reportingPerson":"Deerfield Mgmt, L.P.","reportingCik":null,"personType":"PN","sharesOwned":3070000,"percentOfClass":5.25,"filedAt":"2026-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0002012383-26-003774","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001768446","issuerName":"CLIMB BIO INC","ticker":"CLYM","cusip":"28658R106","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":2895165,"percentOfClass":5,"filedAt":"2026-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001687078-26-000018","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":"28658R106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"MPM BioImpact LLC","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0000315066-26-001452","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001768446","issuerName":"CLIMB BIO INC","ticker":"CLYM","cusip":"28658R106","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":6790364,"percentOfClass":11.9,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0000315066-26-001452","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001768446","issuerName":"CLIMB BIO INC","ticker":"CLYM","cusip":"28658R106","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":6790364,"percentOfClass":11.9,"filedAt":"2026-07-08","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001346824-26-000189","formType":"SCHEDULE 13D/A","amendmentNo":10,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":"28658R106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-07-02","reportingPerson":"Peter Kolchinsky","reportingCik":"0001384859","personType":"HC,IN","sharesOwned":23249186,"percentOfClass":33,"filedAt":"2026-07-07","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001346824-26-000189","formType":"SCHEDULE 13D/A","amendmentNo":10,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":"28658R106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-07-02","reportingPerson":"RA Capital Management, L.P.","reportingCik":"0001346824","personType":"IA,PN","sharesOwned":23249186,"percentOfClass":33,"filedAt":"2026-07-07","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001346824-26-000189","formType":"SCHEDULE 13D/A","amendmentNo":10,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":"28658R106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-07-02","reportingPerson":"Rajeev Shah","reportingCik":"0001619841","personType":"HC,IN","sharesOwned":23249186,"percentOfClass":33,"filedAt":"2026-07-07","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001346824-26-000189","formType":"SCHEDULE 13D/A","amendmentNo":10,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":"28658R106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-07-02","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":"0001315082","personType":"PN","sharesOwned":16934205,"percentOfClass":24.1,"filedAt":"2026-07-07","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001346824-26-000189","formType":"SCHEDULE 13D/A","amendmentNo":10,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":"28658R106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-07-02","reportingPerson":"RA Capital Nexus Fund III, L.P.","reportingCik":"0001883840","personType":"PN","sharesOwned":3671766,"percentOfClass":6.4,"filedAt":"2026-07-07","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001346824-26-000123","formType":"SCHEDULE 13D/A","amendmentNo":9,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":"28658R106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-27","reportingPerson":"RA Capital Management, L.P.","reportingCik":"0001346824","personType":"IA,PN","sharesOwned":22631401,"percentOfClass":33,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001346824-26-000123","formType":"SCHEDULE 13D/A","amendmentNo":9,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":"28658R106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-27","reportingPerson":"Peter Kolchinsky","reportingCik":"0001384859","personType":"HC,IN","sharesOwned":22631401,"percentOfClass":33,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001346824-26-000123","formType":"SCHEDULE 13D/A","amendmentNo":9,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":"28658R106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-27","reportingPerson":"Rajeev Shah","reportingCik":"0001619841","personType":"HC,IN","sharesOwned":22631401,"percentOfClass":33,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001346824-26-000123","formType":"SCHEDULE 13D/A","amendmentNo":9,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":"28658R106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-27","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":"0001315082","personType":"PN","sharesOwned":17123763,"percentOfClass":25,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001346824-26-000123","formType":"SCHEDULE 13D/A","amendmentNo":9,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":"28658R106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-27","reportingPerson":"RA Capital Nexus Fund III, L.P.","reportingCik":"0001883840","personType":"PN","sharesOwned":5346247,"percentOfClass":9.3,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001346824-26-000123","formType":"SCHEDULE 13D/A","amendmentNo":9,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":"28658R106","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-04-27","reportingPerson":"Sera Medicines, LLC","reportingCik":null,"personType":"OO","sharesOwned":2479872,"percentOfClass":4.3,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001687078-26-000006","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"MPM BioImpact LLC","reportingCik":null,"personType":"IA","sharesOwned":2671480,"percentOfClass":5.6,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001346824-25-000074","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001768446","issuerName":"CLIMB BIO, INC.","ticker":"CLYM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-11","reportingPerson":"RA Capital Management, L.P.","reportingCik":"0001346824","personType":"IA,PN","sharesOwned":17953284,"percentOfClass":33,"filedAt":"2025-12-15","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001346824-25-000074","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001768446","issuerName":"CLIMB BIO, INC.","ticker":"CLYM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-11","reportingPerson":"Peter Kolchinsky","reportingCik":"0001384859","personType":"HC,IN","sharesOwned":17953284,"percentOfClass":33,"filedAt":"2025-12-15","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001346824-25-000074","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001768446","issuerName":"CLIMB BIO, INC.","ticker":"CLYM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-11","reportingPerson":"Rajeev Shah","reportingCik":"0001619841","personType":"HC,IN","sharesOwned":17953284,"percentOfClass":33,"filedAt":"2025-12-15","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001346824-25-000074","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001768446","issuerName":"CLIMB BIO, INC.","ticker":"CLYM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-11","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":"0001315082","personType":"PN","sharesOwned":12485646,"percentOfClass":23,"filedAt":"2025-12-15","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001346824-25-000074","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001768446","issuerName":"CLIMB BIO, INC.","ticker":"CLYM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-11","reportingPerson":"RA Capital Nexus Fund III, L.P.","reportingCik":"0001883840","personType":"PN","sharesOwned":5346247,"percentOfClass":11.2,"filedAt":"2025-12-15","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001346824-25-000074","formType":"SCHEDULE 13D/A","amendmentNo":8,"issuerCik":"0001768446","issuerName":"CLIMB BIO, INC.","ticker":"CLYM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-11","reportingPerson":"Sera Medicines, LLC","reportingCik":null,"personType":"OO","sharesOwned":2479872,"percentOfClass":5.2,"filedAt":"2025-12-15","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001193125-25-241629","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-14","reportingPerson":"AI ETI LLC","reportingCik":"0001871741","personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001193125-25-241629","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-14","reportingPerson":"Access Industries Holdings LLC","reportingCik":"0001391297","personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001193125-25-241629","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-14","reportingPerson":"Access Industries Management, LLC","reportingCik":"0001508226","personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001193125-25-241629","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-14","reportingPerson":"Len Blavatnik","reportingCik":"0001326628","personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2025-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001193125-25-233582","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-03","reportingPerson":"AI ETI LLC","reportingCik":"0001871741","personType":"OO","sharesOwned":3835117,"percentOfClass":5.66,"filedAt":"2025-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001193125-25-233582","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-03","reportingPerson":"Access Industries Holdings LLC","reportingCik":"0001391297","personType":"OO","sharesOwned":3835117,"percentOfClass":5.66,"filedAt":"2025-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001193125-25-233582","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-03","reportingPerson":"Access Industries Management, LLC","reportingCik":"0001508226","personType":"OO","sharesOwned":3835117,"percentOfClass":5.66,"filedAt":"2025-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001193125-25-233582","formType":"SCHEDULE 13D/A","amendmentNo":4,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-10-03","reportingPerson":"Len Blavatnik","reportingCik":"0001326628","personType":"IN","sharesOwned":3835117,"percentOfClass":5.66,"filedAt":"2025-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001213900-25-088802","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2024-06-27","reportingPerson":"Pontifax VI G.P. L.P.","reportingCik":null,"personType":"PN","sharesOwned":5206380,"percentOfClass":7.7,"filedAt":"2025-09-18","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001213900-25-088802","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2024-06-27","reportingPerson":"Pontifax Management 4 G.P. (2015) Ltd.","reportingCik":null,"personType":"CO","sharesOwned":5206380,"percentOfClass":7.7,"filedAt":"2025-09-18","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001213900-25-088802","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2024-06-27","reportingPerson":"Ran Nussbaum","reportingCik":null,"personType":"IN","sharesOwned":5206380,"percentOfClass":7.7,"filedAt":"2025-09-18","canonicalUrl":"https://xoomar.com/markets/stocks/clym"},{"accessionNo":"0001213900-25-088802","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001768446","issuerName":"Climb Bio, Inc.","ticker":"CLYM","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2024-06-27","reportingPerson":"Tomer Kariv","reportingCik":null,"personType":"IN","sharesOwned":5206380,"percentOfClass":7.7,"filedAt":"2025-09-18","canonicalUrl":"https://xoomar.com/markets/stocks/clym"}],"updatedAt":"2026-11-04T04:21:20.701Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/clym","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}